Inventor

LADNER ROBERT C

US53 patents

⚠️ This page may combine multiple inventors who share the name “LADNER ROBERT C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LADNER ROBERT C

DYAX CORP

Prevention and reduction of blood loss

Prevention and reduction of blood loss

Prevention and reduction of blood loss

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

Ligand screening and discovery

Inhibitors of human plasmin derived from the Kunitz domains

Prevention and reduction of blood loss

Kallikrein-binding “Kunitz domain” proteins and analogues thereof

Kallikrein-inhibitor therapies

Kallikrein-inhibitor therapies

Antibodies that bind hK-1

Kallikrein-inhibitor therapies

ITI-D1 Kunitz domain mutants as HNE inhibitors

Antibodies that bind MMP-14

Poly-pegylated protease inhibitors

Prevention and reduction of blood loss

HK1-binding proteins

Ligand screening and discovery

Metalloproteinase-binding proteins

LADNER ROBERT C

Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides

Prevention and reduction of blood loss

Prevention and reduction of blood loss

Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries

Libraries of genetic packages comprising novel HC CDR3 designs

Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs

Protease inhibition

Kallikrein-inhibitor therapies

Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries

Methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins

Display library process

PROTEIN ENG CORP

Directed evolution of novel binding proteins

Viruses expressing chimeric binding proteins

Directed evolution of novel binding proteins

Generation and selection of novel DNA-binding proteins and polypeptides

Generation and selection of novel dna-binding proteins and polypeptides

GENEX CORP

Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides

Single polypeptide chain binding molecules

Computer designed stabilized proteins and method for producing same

Computer-based method for designing stablized proteins

ENZON LAB INC

Immunoaffinity purification methods using single polypeptide chain binding molecules

Immunoassay methods using single polypeptide chain binding molecules

Immunotheraphy using single chain polypeptide binding molecules

Single polypeptide chain binding molecules

BLAIR HENRY

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

DEVY LAETITIA

Method for treating breast cancer using antibody binding to MMP-14

Metalloproteinase binding proteins

MARKLAND WILLIAM

Kallikrein-binding “Kunitz domain” proteins and analogues thereof

SATO AARON K

KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy

HOET RENE

Libraries and methods for isolating antibodies